MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner

Molecular and Cellular Biology

Volumn 23, Issue 14, 2003, Pages 4859-4869

  Michels, Annemieke A ^a   Nguyen, Van Trung ^a   Fraldi, Alessandro ^c   Labas, Valérie ^b   Edwards, Mia ^a   Bonnet, François ^a   Lania, Luigi ^c   Bensaude, Olivier ^a  

^a ECOLE NORMALE SUPÉRIEURE   (France)

^b CNRS   (France)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7SK RNA; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; ELONGATION FACTOR; PHOSPHOTRANSFERASE; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN MAQ1; PROTEIN SUBUNIT; SMALL NUCLEAR RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; RNA BINDING; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE 9; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE PRODUCTS, TAT; HELA CELLS; HIV LONG TERMINAL REPEAT; HUMANS; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL NUCLEAR; RNA-BINDING PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

EID: 0038111978     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.14.4859-4869.2003     Document Type: Article

References (66)

1. Barboric, M., R. M. Nissen, S. Kanazawa, N. Jabrane-Ferrat, and B. M. Peterlin. 2001. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8:327-337.
2. Bartel, P. L., and S. Fields. 1995. Analyzing protein-protein interactions using two-hybrid system. Methods Enzymol. 254:241-263.
3. Bentley, D. 2002. The mRNA assembly line: transcription and processing machines in the same factory. Curr. Opin. Cell Biol. 14:336-342.
4. Berkhout, B., R. H. Silverman, and K.-T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282.
5. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:7056-7065.
6. Chao, S. H., and D. H. Price. 2001. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J. Biol. Chem. 276: 31793-31799.
7. Dahmus, M. E. 1996. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271:19009-19012.
8. Darbinian, N., B. E. Sawaya, K. Khalili, N. Jaffe, B. Wortman, A. Giordano, and S. Amini. 2001. Functional interaction between cyclin T1/cdk9 and Purα determines the level of TNFα promoter activation by Tat in glial cells. J. Neuroimmunol. 121:3-11.
9. De Falco, G., L. Bagella, P. P. Claudio, A. De Luca, Y. Fu, B. Calabretta, A. Sala, and A. Giordano. 2000. Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation. Oncogene 19:373-379.
10. Devault, A., A.-M. Martinez, D. Fesquet, J.-C. Labbé, N. Morin, J.-P. Tassan, E. A. Nigg, J.-C. Cavadore, and M. Dorée. 1995. MAT1 ('ménage à trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J. 14:5027-5036.
11. Endicott, J. A., M. E. Noble, and J. A. Tucker. 1999. Cyclin-dependent kinases: inhibition and substrate recognition. Curr. Opin. Struct. Biol. 9:738-744.
12. Estable, M. C., M. H. Naghavi, H. Kato, H. Xiao, J. Qin, A. Vahlne, and R. G. Roeder. 2002. MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein. J. Biomed. Sci. 9:234-245.
13. Fong, Y. W., and Q. Zhou. 2000. Relief of two built-in autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 20:5897-5907.
14. Fraldi, A., P. Licciardo, B. Majello, A. Giordano, and L. Lania. 2001. Distinct regions of cyclin T1 are required for binding to CDK9 and for recruitment to the HIV-1 Tat/TAR complex. J. Cell. Biochem. 36:247-253.
15. Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin. 1999. Interactions between human cyclin T, tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96:1285-1290.
16. Gait, M. J., and J. Karn. 1993. RNA recognition by the human immunodeficiency virus Tat and Rev proteins. Trends Biochem. Sci. 18:255-259.
17. Garber, M. E., and K. A. Jones. 1999. HIV-1 Tat: coping with negative elongation factors. Curr. Opin. Immunol. 11:460-465.
18. Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-3527.
19. Garriga, J., X. Mayol, and X. Graña. 1996. The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes. Biochem. J. 319:293-298.
20. Ghatpande, S., S. Goswami, S. Mathew, G. Rong, L. Cai, S. Shafiq, and M. A. Siddiqui. 1999. Identification of a novel cardiac lineage-associated protein (cCLP-1): a candidate regulator of cardiogenesis. Dev. Biol. 208:210-221.
21. Giudicelli, F., E. Taillebourg, P. Charnay, and P. Gilardi-Hebenstreit. 2001. Krox-20 patterns the hindbrain through both cell-autonomous and non cell-autonomous mechanisms. Genes Dev. 15:567-580.
22. Gürsoy, H. C., D. Koper, and B.-J. Benecke. 2000. The vertebrate 7S K RNA separates hagfish (Myxine glutinosa) and lamprey (Lampetra fluviatilis). J. Mol. Evol. 50:456-464.
23. Hautbergue, G., and V. Goguel. 2001. Activation of the cyclin-dependent kinase CTDK-I requires the heterodimerization of two unstable subunits. J. Biol. Chem. 276:8005-8013.
24. Herrmann, C. H., and M. A. Mancini. 2001. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J. Cell Sci. 114:1491-1503.
25. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
26. Hirose, Y., and J. L. Manley. 2000. RNA polymerase II and the integration of nuclear events. Genes Dev. 14:1415-1429.
27. Huang, F., M. Wagner, and M. A. Siddiqui. 2002. Structure, expression, and functional characterization of the mouse CLP-1 gene. Gene 292:245-259.
28. Kanazawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12:61-70.
29. Kiernan, R. E., S. Emiliani, K. Nakayama, A. Castro, J. C. Labbé, T. Lorca, K. Nakayama Ki, and M. Benkirane. 2001. Interaction between cyclin TI and SCF (SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol. Cell. Biol. 21:7956-7970.
30. Kim, Y. K., C. F. Bourgeois, C. Isel, M. J. Churcher, and J. Karn. 2002. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol. Cell. Biol. 22:4622-4637.
31. Kino, T., O. Slobodskaya, G. N. Pavlakis, and G. P. Chrousos. 2002. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J. Biol. Chem. 277:2396-2405.
32. Kusuhara, M., K. Nagasaki, K. Kimura, N. Maass, T. Manabe, S. Ishikawa, M. Aikawa, K. Miyazaki, and K. Yamaguchi. 1999. Cloning of hexamethylene-bis-acetamide-inducible transcript, HEXIM1, in human vascular smooth muscle cells. Biomed. Res. 20:273-279.
33. Kwak, Y. T., D. Ivanov, J. Guo, E. Nee, and R. B. Gaynor. 1999. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. J. Mol. Biol. 288:57-69.
34. Kwek, K. Y., S. Murphy, A. Furger, B. Thomas, W. O'Gorman, H. Kimura, N. J. Proudfoot, and A. Akoulitchev. 2002. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat. Struct. Biol. 9:800-805.
35. Lanz, R. B., N. J. McKenna, S. A. Onate, U. Albrecht, J. Wong, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97:17-27.
36. Lavoie, S. B., A. L. Albert, H. Handa, M. Vincent, and O. Bensaude. 2001. The peptidyl-prolyl isomerase Pinl interacts with hSpt5 phosphorylated by Cdk9. J. Mol. Biol. 312:675-685.
37. Lee, D. K., H. O. Duan, and C. Chang. 2001. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J. Biol. Chem. 276:9978-9984.
38. Mancebo, H. S., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:2633-2644.
39. Matera, A. G., and D. C. Ward. 1993. Nucleoplasmic organization of small nuclear ribonucleoproteins in cultured human cells. J. Cell Biol. 121:715-727.
40. Nakayama, K., and K. Nakayama. 1998. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays 20:1020-1029.
41. Nguyen, V. T., T. Kiss, A. A. Michels, and O. Bensaude. 2001. 7SK snRNA binds to and inhibits the activity of Cdk9/cyclin T complexes. Nature 414: 322-325.
42. O'Keeffe, B., Y. Fong, D. Chen, S. Zhou, and Q. Zhou. 2000. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated Tat stimulation of HIV-1 transcription. J. Biol. Chem. 275:279-287.
43. Patra, D., S. X. Wang, A. Kumagai, and W. G. Dunphy. 1999. The xenopus Suc1/Cks protein promotes the phosphorylation of G2/M regulators. J. Biol. Chem. 274:36839-36842.
44. Peng, J., Y. Zhu, J. T. Milton, and D. H. Price. 1998. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:755-762.
45. Price, D. H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2629-2634.
46. Proudfoot, N. J., A. Furger, and M. J. Dye. 2002. Integrating mRNA processing with transcription. Cell 108:501-512.
47. Rockx, D. A., R. Mason, A. van Hoffen, M. C. Barton, E. Citterio, D. B. Bregman, A. A. van Zeeland, H. Vrieling, and L. H. Mullenders. 2000. UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II. Proc. Natl. Acad. Sci. USA 97:10503-10508.
48. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
49. Sano, M., M. Abdellatif, H. Oh, M. Xie, L. Bagella, A. Giordano, L. H. Michael, F. J. DeMayo, and M. D. Schneider. 2002. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat. Med. 8:1310-1317.
50. Sano, M., and M. D. Schneider. 2003. Cyclins that don't cycle: cyclin t/cyclin-dependent kinase-9 determines cardiac muscle cell size. Cell Cycle 2:99-104.
51. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68: 850-858.
52. Shi, Y., M. Downes, W. Xie, H. Y. Kao, P. Ordentlich, C.-C. Tsai, M. Hon, and R. M. Evans. 2001. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev. 15:1140-1151.
53. Simone, C., and A. Giordano. 2001. New insight in cdk9 function: from Tat to MyoD. Front Biosci. 6:D1073-D1082.
54. Simone, C., P. Stiegler, L. Bagella, B. Pucci, C. Bellan, G. De Falco, A. De Luca, G. Guanti, P. L. Puri, and A. Giordano. 2002. Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene 21:4137-4148.
55. Sterner, D. E., J. M. Lee, S. E. Hardin, and A. L. Greenleaf. 1995. The yeast carboxyl-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex. Mol. Cell. Biol. 15:5716-5724.
56. Swanton, C., G. L. Card, D. Mann, N. McDonald, and N. Jones. 1999. Overcoming inhibitions: subversion of CKI function by viral cyclins. Trends Biochem. Sci. 24:116-120.
57. Vidal, A., and A. Koff. 2000. Cell-cycle inhibitors: three families united by a common cause. Gene 247:1-15.
58. Watanabe, M., J. Yanagisawa, H. Kitagawa, K. Takeyama, S. Ogawa, Y. Arao, M. Suzawa, Y. Kobayashi, T. Yano, H. Yoshikawa, Y. Masuhiro, and S. Kato. 2001. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J. 15:1341-1352.
59. Wei, P., M. E. Garber, S.-M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
60. Yamaguchi, Y., T. Takagi, T. Wada, K. Yano, A. Furuya, S. Sugimoto, J. Hasegawa, and H. Handa. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97:41-51.
61. Yang, X., M. O. Gold, D. N. Tang, D. E. Lewis, E. Aguilar-Cordova, A. P. Rice, and C. H. Herrmann. 1997. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA 94:12331-12336.
62. Yang, Z., Q. Zhu, K. Luo, and Q. Zhou. 2001. The 7SK small nuclear RNA inhibits the CDK9/cyclin Ti kinase to control transcription. Nature 414:317-322.
63. Zhang, J., N. Tamilarasu, S. Hwang, M. E. Garber, I. Huq, K. A. Jones, and T. M. Rana. 2000. HIV-1 TAR RNA enhances the interaction between Tat and cyclin Ti. J. Biol. Chem. 275:34314-34319.
64. Zhou, M., M. A. Halanski, M. F. Radonovich, F. Kashanchi, J. Peng, D. H. Price, and J. N. Brady. 2000. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20:5077-5086.
65. Zhou, Q., D. Chen, E. Pierstorff, and K. Luo. 1998. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:3681-3691.
66. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:2622-2632.